VB
Vyant Bio
Publications
- yahoo.com1 article
- Vyant Bio Announces Last Day of Trading on Nasdaq and Filing of Form 15 for Voluntary Nasdaq Delisting and SEC Deregistration12 May 2023—yahoo.comCHERRY HILL, N.J., May 12, 2023 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio” or “Company”) (Nasdaq: VYNT) is a biotechnology company that incorporates innovative biology and data science to improve drug discovery for complex neurodevelopmental and neurodegenerative disorders. The Company’s proprietary central nervous system (“CNS”) drug discovery platform combines human-derived organoid models of brain disease, scaled biology, and machine learning. As previously announced, Vyant Bio filed...
People Also Viewed
- Chief Correspondent, Energy Transition at Thomson Reuters
- Fox Business
- Yahoo Finance